CorrectSequence Therapeutics Co., Ltd
CorrectSequence Therapeutics Co., Ltd
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Not yet recruiting | Early phase 1 | 2026-06-18 | NCT07657780 | |
| CS-101 in Patients With β-thalassemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Enrolling by invitation | Early phase 1 | 2026-06-09 | NCT06328764 | |
| A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major | β-thalassemia Major | Not yet recruiting | Phase 2 | 2026-03-24 | NCT07489196 | |
| CS-121 APOC3 Base Editing in FCS | Digestive System Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, familial lipoprotein lipase deficiency, hyperlipidemia, hypertriglyceridemia, metabolic disease, pancreas disorder, pancreatitis | Recruiting | Early phase 1 | 2026-02-11 | NCT07176923 | |
| A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Enrolling by invitation | Not stated | 2026-02-10 | NCT06717932 | |
| A Long-term Follow-up Study in Participants Who Received CS-101 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Enrolling by invitation | Not stated | 2026-02-10 | NCT06685536 | |
| CS-206 in Patients With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Early phase 1 | 2026-02-10 | NCT06565026 | |
| CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial lipoprotein lipase deficiency, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease, pancreas disorder, pancreatitis | Recruiting | Early phase 1 | 2026-01-28 | NCT07371767 |